PERSPECTA

News from every angle

← Back to headlines

MiMedx Outlines 2027 Revenue Targets Exceeding $400M Post-Sanara Deal

MiMedx has projected its 2027 revenue to be well over $400 million with an adjusted EBITDA margin exceeding 20%, following its planned deal with Sanara.

30 Jul, 04:34 — 30 Jul, 04:34
PostShare

Sources

Showing 1 of 1 sources
seeking-alphaMixed9d ago

MiMedx outlines 2027 revenue well in excess of $400M with over 20% adjusted EBITDA margin following planned Sanara deal

Read full article →

Related Stories

England Discards 3,400 Tons of Unused Medicines Annually

17m ago

Omniva Redirects Packages to Manage High Delivery Volumes

22m ago

AI-Enhanced Photos on Vinted Raise Concerns About Misleading Ads

23m ago

Slovenian Fuel Prices Expected to Drop Significantly

25m ago